PA
GILD icon

Perceptive Advisors’s Gilead Sciences GILD Stock Holding History

Perceptive Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100,000
Closed -$9.82M – 163
2015
Q3 		$9.82M Sell
100,000
-100,000
-50% -$11.1M 0.78% 30
2015
Q2 		$23.4M Buy
+200,000
New +$21.9M 1.41% 15
2013
Q3 		– Hold
0
– -$2.48M – 113
2013
Q2 		– Hold
0
– – – 44

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors's GILD Position: Q2 2020 in Review

Perceptive Advisors sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 1,500,000 shares — an estimated $11.2M sold.

Perceptive Advisors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $54.3M in Q3 2013. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Perceptive Advisors reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Perceptive Advisors sold 1,500,000 Gilead Sciences shares in Q2 2020, an estimated $11.2M.
  • Perceptive Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Perceptive Advisors's Gilead Sciences position peaked at $54.3M in Q3 2013.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.